Last update 23 Jan 2025

Jilai'An (Shanghai) Biological Technology Co Ltd

Private Company|
2018|
Shanghai Shi, China

Overview

Tags

Digestive System Disorders
Hemic and Lymphatic Diseases
Neoplasms
Small molecule drug

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Hemic and Lymphatic Diseases1
Neoplasms1
Top 5 Drug TypeCount
Small molecule drug1
Top 5 TargetCount
FLT3 x PDGFR x c-Kit1

Related

1
Drugs associated with Jilai'An (Shanghai) Biological Technology Co Ltd
Crenolanib Besylate
Target
FLT3 x PDGFR x c-Kit
Mechanism
FLT3 inhibitors [+2]
Active Org.
Pfizer Inc.Pfizer Inc. [+2]
Originator Org.
Pfizer Inc.Pfizer Inc.
Active Indication
FLT3 positive Acute Myeloid Leukemia [+1]
Inactive Indication
Acute Myeloid Leukemia with FLT3/ITD Mutation [+16]
Drug Highest PhasePhase 3
First Approval Ctry. / Loc.-
First Approval Date-
1
Clinical Trials associated with Jilai'An (Shanghai) Biological Technology Co Ltd
CTR20200493
/ Not yet recruitingPhase 3
Crenolanib联合化疗对比单用化疗在复发/难治 FLT3 突变AML中疗效的III期临床研究
[Translation] A phase III clinical study of the efficacy of crenolanib combined with chemotherapy versus chemotherapy alone in relapsed/refractory FLT3 mutant AML
100 Clinical Results associated with Jilai'An (Shanghai) Biological Technology Co Ltd
Login to view more data
0 Patents (Medical) associated with Jilai'An (Shanghai) Biological Technology Co Ltd
Login to view more data
100 Deals associated with Jilai'An (Shanghai) Biological Technology Co Ltd
Login to view more data
100 Translational Medicine associated with Jilai'An (Shanghai) Biological Technology Co Ltd
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 25 Jan 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Phase 3 Clinical
1
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Crenolanib Besylate
 ( FLT3 x PDGFR x c-Kit )		FLT3 positive Acute Myeloid Leukemia
More
Phase 3
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free